Binex Co., Ltd.
Founded in 1985 and listed on KOSDAQ in 2001, Binex is a chemical pharmaceutical and biopharmaceutical CDMO company.
As of 2026-10-11, Binex Co., Ltd. has 267 Korean MFDS drug approvals, 6 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Products & technology
- AntidiarrhealGastrointestinal treatment
- Eye dropsOphthalmic solution
- Biopharmaceutical CDMO serviceCell line development, process development, GMP drug substance and drug product manufacturing
Regulatory approvals
data.go.kr267 Korean MFDS drug approvals · 1979–2026
- MFDS drugTwinspin-S Tab. 40/2.5mg2026-07-28Drug · Prescription · Approval202602173
- MFDS drugTwinspin-S Tab. 40/5mg2026-07-28Drug · Prescription · Approval202602174
- MFDS drugTwinspin-S Tab. 80/2.5mg2026-07-28Drug · Prescription · Approval202602175
- MFDS drugTwinspin-S Tab. 80/5mg2026-07-28Drug · Prescription · Approval202602176
- MFDS drugPitanex Tab. 1mg2026-06-29Drug · Prescription · Approval202601830
- MFDS drugIbron Syr.2026-04-14Drug · OTC · Notification202601084
- MFDS drugCitu-care Tab 50mg (Pranlukast Hydrate)2026-01-30Drug · Prescription · Approval202600277
- MFDS drugBiscan Pro-duo Cap.2025-07-24Drug · OTC · Notification202501886
- MFDS drugPitanewfen Cap.2025-07-11Drug · Prescription · Approval202501756
- MFDS drugProbiomeC Cap.2025-03-20Drug · OTC · Notification202500636
- MFDS drugFlora7 Cap.2025-03-20Drug · OTC · Notification202500637
- MFDS drugCit-Q Tab.2025-03-18Drug · OTC · Notification202500603
Show 68 more
- MFDS drugBromferine Eye Drops(Bromfenac Sodium Hydrate)(Single use)2024-10-28Drug · Prescription · Approval202402538
- MFDS drugGinkgobila Tab. 240mg2024-08-28Drug · OTC · Notification202402078
- MFDS drugDimenceline Tab. 30mg2024-06-24Drug · Prescription · Approval202401520
- MFDS drugJamein Tab.2024-01-16Drug · OTC · Notification202400104
- MFDS drugMarothin Tab.2023-12-18Drug · OTC · Notification202303360
- MFDS drugBiscan-B Cap.2023-09-22Drug · OTC · Notification202302804
- MFDS drugBiscan-B Pow.2023-09-15Drug · OTC · Notification202302766
- MFDS drugLukalevo Tab.2023-08-25Drug · Prescription · Approval202302518
- MFDS drugProB7 Pow.2023-07-24Drug · OTC · Notification202302223
- MFDS drugProB7 Cap.2023-07-24Drug · OTC · Notification202302230
- MFDS drugNune Fresh Eye Drops 1.0% (single use)2023-06-07Drug · OTC · Notification202301765
- MFDS drugDapoxi Tab. 10mg2023-01-16Drug · Prescription · Approval202300256
- MFDS drugFimalopine Tab. 30/2.5mg2023-01-06Drug · Prescription · Approval202300084
- MFDS drugFimalopine Tab. 60/5mg2023-01-06Drug · Prescription · Approval202300099
- MFDS drugFimalopine Tab. 60/2.5mg2023-01-06Drug · Prescription · Approval202300126
- MFDS drugDamet XR Tab. 5/500mg2022-11-10Drug · Prescription · Approval202204073
- MFDS drugDamet XR Tab. 10/500mgRevoked2022-11-10Drug · Prescription · Approval202204074
- MFDS drugAlepro Eye Drops 0.7% (single use)2022-08-03Drug · Prescription · Approval202203178
- MFDS drugDoxic Tab.50mg2022-06-30Drug · Prescription · Approval202202687
- MFDS drugTineglip M SR Tab. 20/1000mg2022-04-04Drug · Prescription · Approval202201420
- MFDS drugTineglip M SR Tab. 10/750mg2022-04-04Drug · Prescription · Approval202201421
- MFDS drugTineglip M SR Tab. 10/500mg2022-04-04Drug · Prescription · Approval202201422
- MFDS drugNexgliptinduo Tab. 50/1000mg2022-01-06Drug · Prescription · Approval202200117
- MFDS drugNexgliptinduo Tab. 50/500mg2022-01-06Drug · Prescription · Approval202200118
- MFDS drugNexgliptinduo Tab. 50/850mg2022-01-06Drug · Prescription · Approval202200119
- MFDS drugForxivia Tab. 10/100mg2022-01-04Drug · Prescription · Approval202200051
- MFDS drugEso-oh Tab. 20/800mg2021-11-10Drug · Prescription · Approval202107426
- MFDS drugDamet XR Tab. 10/1000mg2021-10-13Drug · Prescription · Approval202106882
- MFDS drugDamet XR Tab. 5/1000mg2021-10-13Drug · Prescription · Approval202106883
- MFDS drugBi-Tofacitinib Tab. 5mgRevoked2021-02-05Drug · Prescription · Approval202101128
- MFDS drugTineglip Tab. 20mg2021-02-02Drug · Prescription · Approval202101004
- MFDS drugDITUIN B Tab.Revoked2020-10-29Drug · OTC · Notification202007412
- MFDS drugRimotec tab. 100mgRevoked2020-08-13Drug · OTC · Notification202005794
- MFDS drugNexgliptin Tab. 100mg2020-08-03Drug · Prescription · Approval202005610
- MFDS drugNexgliptin Tab. 50mg2020-08-03Drug · Prescription · Approval202005611
- MFDS drugNexgliptin Tab. 25mg2020-08-03Drug · Prescription · Approval202005612
- MFDS drugArtifosol eye drops 3% (disposable)2020-06-29Drug · Prescription · Approval202004705
- MFDS drugLevotra eye drops 1.5%2020-06-29Drug · Prescription · Approval202004754
- MFDS drugMonospinplus Tab. 40/12.5mgRevoked2020-06-11Drug · Prescription · Approval202004333
- MFDS drugMonospinplus Tab. 80/12.5mgRevoked2020-06-11Drug · Prescription · Approval202004334
- MFDS drugEpinys Tab.Revoked2020-05-13Drug · Prescription · Approval202003467
- MFDS drugPolamac Tab.Revoked2020-04-23Drug · Prescription · Approval202002932
- MFDS drugBinex tamsulosinHCl SR Tab. 0.4mg2020-04-17Drug · Prescription · Approval202002734
- MFDS drugAnfera Cap.2020-02-28Drug · OTC · Notification202001421
- MFDS drugLinatra duo tab. 2.5/1000mg2020-02-24Drug · Prescription · Approval202001309
- MFDS drugLinatra duo tab. 2.5/850mg2020-02-24Drug · Prescription · Approval202001310
- MFDS drugLinatra duo tab. 2.5/500mg2020-02-24Drug · Prescription · Approval202001311
- MFDS drugTialduo Tab. 40/20mgRevoked2020-02-19Drug · Prescription · Approval202001159
- MFDS drugTialduo Tab. 80/20mgRevoked2020-02-19Drug · Prescription · Approval202001160
- MFDS drugMachpezil ODT Tab. 10mgRevoked2019-12-12Drug · Prescription · Approval201908363
- MFDS drugMachpezil ODT Tab. 5mgRevoked2019-12-12Drug · Prescription · Approval201908364
- MFDS drugBimo Tab.5mg2019-12-06Drug · Prescription · Notification201908280
- MFDS drugThegainD Tab.2019-10-31Drug · OTC · Notification201907628
- MFDS drugTirinta tab. 90mgRevoked2019-10-11Drug · Prescription · Approval201907179
- MFDS drugTialduo Tab. 40/5mgRevoked2019-09-30Drug · Prescription · Approval201906976
- MFDS drugTialduo Tab. 40/10mgRevoked2019-09-30Drug · Prescription · Approval201906977
- MFDS drugTialduo Tab. 80/5mgRevoked2019-09-30Drug · Prescription · Approval201906978
- MFDS drugTialduo Tab. 80/10mgRevoked2019-09-30Drug · Prescription · Approval201906979
- MFDS drugTirinta tab. 60mgRevoked2019-09-19Drug · Prescription · Approval201906562
- MFDS drugEmperisone SR Tab.2019-08-22Drug · Prescription · Approval201905950
- MFDS drugLinatra Tab. 5mg2019-07-12Drug · Prescription · Approval201904712
- MFDS drugCilovel SR Cap. 200mg2019-05-31Drug · Prescription · Approval201903653
- MFDS drugCilovel SR Cap. 100mg2019-05-31Drug · Prescription · Approval201903654
- MFDS drugSevitan HCT Tab. 5/20/12.5mgRevoked2019-05-31Drug · Prescription · Approval201903602
- MFDS drugSevitan HCT Tab. 5/40/12.5mgRevoked2019-05-31Drug · Prescription · Approval201903603
- MFDS drugEcathina Tab.Revoked2019-05-28Drug · OTC · Notification201903448
- MFDS drugTheon Cap. 300mgRevoked2019-05-23Drug · Prescription · Notification201903350
- MFDS drugDiart Cap.Revoked2019-05-16Drug · Prescription · Approval201903175
Showing the 80 most recent of 267 records.
Clinical trials
data.go.kr39 MFDS clinical trial authorisations · 2012–2026 (Bioequivalence 39)
- Bioequivalence모노스핀정80밀리그램(텔미사르탄)2026-01-20
2 trial sites
- Bioequivalence피타뉴젯정4/10밀리그램(피타바스타틴칼슘, 에제티미브)2025-04-30
2 trial sites
- Bioequivalence바이모정5밀리그램(미녹시딜)2024-02-06
2 trial sites
- Bioequivalence디멘세린정30밀리그램(니세르골린)2023-06-16
2 trial sites
- Bioequivalence펜트민정(펜터민염산염)2023-06-05
2 trial sites
- Bioequivalence펜디씬정(펜디메트라진타르타르산염)2023-06-01
2 trial sites
- Bioequivalence바이모정5밀리그램(미녹시딜)2023-05-08
2 trial sites
- Bioequivalence트윈스핀정40/5mg2022-06-02
2 trial sites
- Bioequivalence모노스핀정80밀리그램(텔미사르탄)2022-05-31
2 trial sites
- Bioequivalence바이넥스세파클러캡슐(세파클러수화물)2022-05-20
2 trial sites
- Bioequivalence피타넥스정(피타바스타틴칼슘)2022-02-15
1 trial site
- Bioequivalence다포시정10밀리그램(다파글리플로진프로판디올수화물)2022-02-15
1 trial site
Show 27 more
- Bioequivalence넥스라졸정40밀리그램(에스오메프라졸마그네슘삼수화물)2022-02-09
1 trial site
- Bioequivalence트윈스핀정80/5mg2022-01-18
1 trial site
- Bioequivalence암로원정(암로디핀베실산염)2021-10-29
2 trial sites
- Bioequivalence바이피토정10밀리그램(아토르바스타틴칼슘삼수화물)2021-02-18
2 trial sites
- Bioequivalence바이넥스모니플루메이트정2020-12-30
1 trial site
- Bioequivalence로수넥스정10mg(로수바스타틴칼슘)2020-12-17
2 trial sites
- Bioequivalence독시크정50밀리그램(독시사이클린수화물)2020-07-31
2 trial sites
- Bioequivalence바이모틴정5밀리그램(모사프리드시트르산염수화물)2020-03-17
2 trial sites
- Bioequivalence독시크정50밀리그램(독시사이클린수화물)2018-04-20
2 trial sites
- Bioequivalence프레스타캡슐150밀리그램(프레가발린)2017-11-24
2 trial sites
- Bioequivalence펜디씬1/2정(펜디메트라진타르타르산염)2016-12-05
2 trial sites
- Bioequivalence프레스타캡슐150밀리그램(프레가발린)2016-04-29
2 trial sites
- Bioequivalence바이넥스티카그렐러정90밀리그램2015-09-14
2 trial sites
- Bioequivalence바이넥스탐스로신염산염정2015-06-18
2 trial sites
- Bioequivalence바이넥스칸데사르탄실렉세틸정16mg(가칭)2015-06-10
2 trial sites
- Bioequivalence바이피토정10밀리그램(아토르바스타틴칼슘)2015-06-02
2 trial sites
- Bioequivalence프레스타캡슐75밀리그램(프레가발린)2015-05-22
2 trial sites
- Bioequivalence로수넥스정10mg(로수바스타틴칼슘)2015-05-21
2 trial sites
- Bioequivalence바이넥스테노포비르디소프록실푸마르산염정(가칭)2015-05-20
2 trial sites
- Bioequivalence넥스라졸정40밀리그램(에스오메프라졸마그네슘이수화물)2015-05-20
2 trial sites
- Bioequivalence니찌이꼬란소프라졸구강붕해정30mg(가칭)2014-06-30
2 trial sites
- Bioequivalence펜디씬정(펜디메트라진타르타르산염)2014-05-09
2 trial sites
- Bioequivalence올메암로정 10/40밀리그램2013-09-02
1 trial site
- Bioequivalence라베넥스정20밀리그램(라베프라졸나트륨 20mg)2013-08-19
2 trial sites
- Bioequivalence바이넥스타다라필정(가칭)2013-03-20
2 trial sites
- Bioequivalence바이넥스로수바스타틴칼슘정(가칭)(로수바스타틴칼슘)2013-01-29
2 trial sites
- Bioequivalence토파씬정(토피라메이트)2012-07-20
2 trial sites
Global clinical trials
ClinicalTrials.gov · sponsor-matchedPhase 1/2 · Unknown · 2009-01 · NCT00854971
Phase 1/2 · Unknown · 2009-01 · NCT00854854
Key disclosures
KRX KIND via OpenDARTPublications
PubMed · affiliation-matched- Relative Quantitative Analysis of Site-Specific N-Linked Glycosylation in Hyperglycosylated Interferon-β via Mass Spectrometry.
International journal of molecular sciences · 2026-09 · Moon D, Kim G, Park M 외 5
- Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants.
Antiviral research · 2023-04 · Kim JW, Heo K, Kim HJ 외 16
- Stability and Activity of the Hyperglycosylated Human Interferon-β R27T Variant.
Scientific reports · 2020-05 · Song K, Moon DB, Kim NY 외 1
- Optimization of cryopreservation condition for hematopoietic stem cells from umbilical cord blood.
Cryobiology · 2010-06 · Son JH, Heo YJ, Park MY 외 2
- The cryopreservation of high concentrated PBMC for dendritic cell (DC)-based cancer immunotherapy.
Cryobiology · 2009-04 · Heo YJ, Son CH, Chung JS 외 2
- Comparison of level of NKG2D ligands between normal and tumor tissue using multiplex RT-PCR.
Cancer investigation · 2007-08 · Park SW, Bae JH, Kim SD 외 10
Patents
KIPRIS · applicant-matchedPCT · Published · 2024-09 · Application PCT/JP2024/032496
PCT · Published · 2024-03 · Application PCT/JP2024/012764
Expired · 2017-08 · Application 1020170106320
Registered · 2017-08 · Application 1020170099242
Rejected · 2015-08 · Application 1020150110065
Rejected · 2011-03 · Application 1020110022427
Rejected · 2009-12 · Application 1020090119650
Expired · 2009-05 · Application 1020090043003
Registered · 2008-09 · Application 1020080091957
Rejected · 2008-06 · Application 1020080057624
Show 52 more patents
Rejected · 2007-12 · Application 1020070135166
Expired · 2007-12 · Application 1020070134699
Expired · 2007-12 · Application 1020070126060
Registered · 2007-11 · Application 1020070121459
Expired · 2007-06 · Application 1020070059625
PCT · Published · 2007-06 · Application PCT/KR2007/002781
Rejected · 2007-05 · Application 1020070049420
Registered · 2007-05 · Application 1020070046070
CN · Published · 2007-04 · Application 200780031143
US · Published · 2007-04 · Application 12438148
EP · Published · 2007-04 · Application 07746055.8
PCT · Published · 2007-04 · Application PCT/KR2007/001893
Expired · 2006-10 · Application 1020060104653
Expired · 2006-10 · Application 1020060099244
Expired · 2006-09 · Application 1020060092203
Expired · 2006-08 · Application 1020060077872
Expired · 2006-06 · Application 1020060051901
Expired · 2006-06 · Application 1020060050030
Expired · 2006-05 · Application 1020060045588
Expired · 2005-11 · Application 1020050106489
- Subsidiary: (주)바이젠무독화 옻 추출물의 제조 방법 및 그 추출물의 용도
Expired · 2005-10 · Application 1020050101181
Expired · 2005-10 · Application 1020050093533
Expired · 2005-09 · Application 1020050081130
Expired · 2005-05 · Application 1020050044658
Expired · 2004-09 · Application 1020040070649
Expired · 2004-09 · Application 1020040070648
Expired · 2004-04 · Application 1020040024900
Expired · 2004-03 · Application 1020040016655
Rejected · 2004-02 · Application 1020040013667
Expired · 2003-12 · Application 1020030090396
EP · Registered · 2003-11 · Application 03774329.1
PCT · Published · 2003-11 · Application PCT/KR2003/002572
- Subsidiary: (주)바이젠무독화 옻 추출물의 제조 방법 및 그 추출물의 용도
Expired · 2003-10 · Application 1020030071302
Expired · 2003-03 · Application 1020030016220
Expired · 2002-11 · Application 1020020074834
Expired · 2002-05 · Application 1020020024577
Expired · 2002-04 · Application 1020020022150
- Subsidiary: (주)바이젠옻의 무독화 처리방법
Expired · 2002-04 · Application 1020020019904
Rejected · 2002-03 · Application 1020020014075
- Subsidiary: (주)바이젠인터넷을 통한 단계별 학습 방법
Abandoned · 2000-12 · Application 1020000085468
Expired · 2000-08 · Application 1020000045609
Expired · 2000-07 · Application 1020000043356
Expired · 2000-05 · Application 1020000024514
Expired · 1999-10 · Application 1020017004960
EP · Registered · 1999-10 · Application 99951229.6
Expired · 1999-05 · Application 1019990015998
Withdrawn · 1998-10 · Application 1019980044339
Withdrawn · 1998-10 · Application 1019980044340
Expired · 1998-02 · Application 1019980006313
Expired · 1997-09 · Application 1019970047382
Expired · 1997-09 · Application 1019970047383
Expired · 1996-04 · Application 1019960011101
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive2
- OpenAIOAI-SearchBot70
- PerplexityPerplexityBot3
- GoogleGoogleOther2
- AnthropicClaudeBot2
- MicrosoftBingbot1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 10, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Binex Co., Ltd. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies in the same categoryPharma & CDMO
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.
Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition